Innovative Medical Management Co.,Ltd. (SHE:002173)
China · Delayed Price · Currency is CNY 29.07
+0.08 (0.28%)
Feb 13, 2026, 10:55 AM CST
SHE:002173 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 799.23 | 812.14 | 803.89 | 708.34 | 709.37 | 721.97 |
Other Revenue | 3.88 | 3.88 | 1.69 | 1.36 | 2.15 | 2.27 |
| 803.11 | 816.02 | 805.59 | 709.7 | 711.52 | 724.24 | |
Revenue Growth (YoY) | -0.71% | 1.29% | 13.51% | -0.26% | -1.76% | -16.96% |
Cost of Revenue | 740.58 | 752.53 | 714 | 679.5 | 664.14 | 698.25 |
Gross Profit | 62.53 | 63.49 | 91.58 | 30.2 | 47.38 | 26 |
Selling, General & Admin | 112.59 | 114.89 | 118.02 | 118.82 | 122.12 | 127.17 |
Research & Development | 0.57 | - | - | - | - | - |
Other Operating Expenses | 10.94 | 11.11 | 9.68 | 3.7 | 6.52 | 6.33 |
Operating Expenses | 119.92 | 128.42 | 131.05 | 120.19 | 132.15 | 137.64 |
Operating Income | -57.39 | -64.93 | -39.47 | -89.99 | -84.78 | -111.64 |
Interest Expense | -4.18 | -4.09 | -3.65 | -3.35 | -6.06 | -7.64 |
Interest & Investment Income | 31.19 | 7.92 | 17.42 | 17.98 | 19.87 | 19.6 |
Other Non Operating Income (Expenses) | -2.09 | -1.14 | -0.43 | -6.94 | 2.41 | 2 |
EBT Excluding Unusual Items | -32.47 | -62.24 | -26.13 | -82.3 | -68.55 | -97.69 |
Impairment of Goodwill | - | - | - | - | - | -126.97 |
Gain (Loss) on Sale of Investments | 5.48 | 1.98 | -1.84 | - | 9.04 | 3.52 |
Gain (Loss) on Sale of Assets | -0.78 | -1.42 | 1.06 | -1.16 | 0.06 | 0.04 |
Asset Writedown | -3.3 | -3.39 | -5.26 | -11.6 | -1.24 | -16.92 |
Legal Settlements | -34.89 | -34.89 | -3.17 | -15.59 | -40.59 | -43.31 |
Other Unusual Items | -0.67 | -0.67 | 0.38 | 35.36 | -1.79 | -3.63 |
Pretax Income | -66.64 | -100.63 | -34.96 | -75.28 | -103.08 | -284.95 |
Income Tax Expense | -5.02 | -6.65 | -0.68 | -1.69 | 0.27 | 29.45 |
Earnings From Continuing Operations | -61.62 | -93.99 | -34.29 | -73.6 | -103.36 | -314.4 |
Net Income to Company | -61.62 | -93.99 | -34.29 | -73.6 | -103.36 | -314.4 |
Minority Interest in Earnings | 0.24 | 0.03 | 0 | 0.17 | -0.11 | -0.1 |
Net Income | -61.39 | -93.95 | -34.29 | -73.42 | -103.46 | -314.5 |
Net Income to Common | -61.39 | -93.95 | -34.29 | -73.42 | -103.46 | -314.5 |
Shares Outstanding (Basic) | 454 | 447 | 429 | 445 | 450 | 456 |
Shares Outstanding (Diluted) | 454 | 447 | 429 | 445 | 450 | 456 |
Shares Change (YoY) | 2.54% | 4.39% | -3.77% | -0.99% | -1.31% | 0.28% |
EPS (Basic) | -0.14 | -0.21 | -0.08 | -0.16 | -0.23 | -0.69 |
EPS (Diluted) | -0.14 | -0.21 | -0.08 | -0.16 | -0.23 | -0.69 |
Free Cash Flow | 5.97 | -54.3 | -85.21 | -147.62 | -67.35 | 23.31 |
Free Cash Flow Per Share | 0.01 | -0.12 | -0.20 | -0.33 | -0.15 | 0.05 |
Gross Margin | 7.79% | 7.78% | 11.37% | 4.26% | 6.66% | 3.59% |
Operating Margin | -7.15% | -7.96% | -4.90% | -12.68% | -11.92% | -15.42% |
Profit Margin | -7.64% | -11.51% | -4.26% | -10.35% | -14.54% | -43.43% |
Free Cash Flow Margin | 0.74% | -6.65% | -10.58% | -20.80% | -9.47% | 3.22% |
EBITDA | 19.32 | 23 | 56.87 | 8.77 | 30.91 | 0.19 |
EBITDA Margin | 2.41% | 2.82% | 7.06% | 1.23% | 4.34% | 0.03% |
D&A For EBITDA | 76.71 | 87.93 | 96.34 | 98.76 | 115.69 | 111.84 |
EBIT | -57.39 | -64.93 | -39.47 | -89.99 | -84.78 | -111.64 |
EBIT Margin | -7.15% | -7.96% | -4.90% | -12.68% | -11.92% | -15.42% |
Revenue as Reported | 803.11 | 816.02 | 805.59 | 709.7 | 711.52 | 724.24 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.